Mannitol Causes Hypernatremia, Not Hyponatremia
Mannitol primarily causes hypernatremia through osmotic diuresis and volume depletion, though paradoxical hyponatremia can occur acutely through plasma volume expansion. The FDA drug label explicitly warns about hypernatremia as a complication, while hyponatremia is listed as a consequence of overdosage and excessive fluid shifts 1.
Primary Effect: Hypernatremia
The dominant electrolyte disturbance with mannitol is hypernatremia, occurring through two mechanisms:
- Osmotic diuresis: Mannitol induces significant water loss exceeding sodium loss, concentrating serum sodium 2
- Volume depletion: The diuretic effect requires volume compensation to prevent hypernatremia 2
Clinical evidence demonstrates hypernatremia occurs in 10-21% of patients receiving repeated mannitol doses over 7 days 3. A 2013 study identified mannitol use as an independent risk factor for hospital-acquired hypernatremia (P < 0.001) 4. The 2018 traumatic brain injury guidelines specifically note that hypertonic saline "exposes to hypernatremia" while mannitol requires "volume compensation" to prevent this complication 2.
Paradoxical Acute Hyponatremia
Hyponatremia can occur acutely through plasma volume expansion, but this is less common and typically transient:
- Mannitol causes 12% plasma volume expansion peaking at 15 minutes post-infusion 5
- This dilutional effect can drop serum sodium acutely 5
- Hyponatremia was observed in 12.2% on day 1 of administration but occurred in only 9-24% throughout 7-day periods 3
The FDA label confirms hyponatremia occurs with "too rapid infusion of large amounts" causing "shift of intracellular water into the extracellular compartment" 1. However, this is explicitly described as an overdosage complication, not the expected effect.
Comparative Evidence
A 2019 meta-analysis comparing mannitol to hypertonic saline in traumatic brain injury found mannitol caused significantly lower serum sodium (SMD -8.0 mmol/L; P<0.00001) 6. Similarly, in elective craniotomy, mannitol decreased serum sodium by -6.2 mmol/L compared to hypertonic saline (P=0.0002) 6. However, these comparisons show mannitol causes less hypernatremia than hypertonic saline, not that it causes hyponatremia.
Clinical Monitoring Requirements
The 2018 TBI guidelines mandate monitoring fluid, sodium and chloride balances with both osmotic agents 2. The 2023 subarachnoid hemorrhage guidelines note mannitol "can cause hypovolemia and hypotension" while hypertonic saline "increases blood sodium" 7.
Key Monitoring Points:
- Check sodium levels before and after each dose
- Maintain adequate volume replacement
- Discontinue if serum sodium exceeds 145 mEq/L
- Watch for signs of volume depletion (hypotension, oliguria)
Common Pitfall
The critical error is assuming mannitol's hypertonic nature automatically causes hypernatremia while missing the acute dilutional hyponatremia from volume expansion. In reality, the osmotic diuresis effect dominates clinically, making hypernatremia the primary concern requiring volume compensation 2, 1.